Clofarabine

From WikiMD's Wellness Encyclopedia

(Redirected from Evoltra)

What is Clofarabine?[edit | edit source]



What are the uses of this medicine?[edit | edit source]


How does this medicine work?[edit | edit source]

  • Clofarabine (kloe far' a been) is a purine analogue that is used in the treatment of acute lymphoblastic leukemia (ALL) in children and is used off-label in other forms of leukemia and myelodysplastic syndromes. Clofarabine is a fluorinated arabinosyladenine derivative that is converted intracellularly to the active triphosphate, which is believed to compete with adenine triphosphate for uptake and use by DNA polymerase leading to inhibition of DNA synthesis.


Who Should Not Use this medicine ?[edit | edit source]

  • This medicine have no usage limitations.


What drug interactions can this medicine cause?[edit | edit source]

  • No formal drug interaction studies have been conducted with Clolar.


Is this medicine FDA approved?[edit | edit source]

  • Clofarabine was found to have activity against acute leukemia and was approved for use as an antineoplastic agent in the United States in 2004. C
  • urrent indications are therapy of acute lymphoblastic leukemia in children after failure of prior therapies.


How should this medicine be used?[edit | edit source]

Recommended dosage:

  • Administer the recommended pediatric dose of 52 mg/m2 as an intravenous infusion over 2 hours daily for 5 consecutive days of a 28-day cycle.
  • Repeat cycles every 2-6 weeks.
  • Provide supportive care, such as intravenous infusion fluids, antihyperuricemic treatment, and alkalinization of urine throughout the 5 days of Clofarabine Injection administration to reduce the risk of tumor lysis and other adverse reactions.
  • Discontinue Clofarabine Injection if hypotension develops during the 5 days of administration.
  • Reduce the dose in patients with renal impairment.
  • Use dose modification for toxicity.

Administration:

  • Administer the recommended pediatric dose as an intravenous infusion over 2 hours daily for 5 consecutive days of a 28-day cycle.
  • Repeat cycles every 2-6 weeks.


What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • As Injection: 20 mg/20 mL (1 mg/mL) single-dose vial

This medicine is available in fallowing brand namesː

  • Clolar


What side effects can this medication cause?[edit | edit source]

The most common side effects of this medicine include:


What special precautions should I follow?[edit | edit source]

  • Clofarabine causes myelosuppression which may be severe and prolonged. May be severe and prolonged. Monitor complete blood counts and platelet counts during Clofarabine therapy.
  • Serious and fatal hemorrhage, including cerebral, gastrointestinal and pulmonary hemorrhage, has occurred. Monitor platelets and coagulation parameters and treat accordingly.
  • Clofarabine increases the risk of infection, including severe and fatal sepsis, and opportunistic infections. Monitor for signs and symptoms of infection; discontinue Clofarabine and treat promptly.
  • Administration of Clofarabine may result in tumor lysis syndrome associated with the break-down metabolic products from peripheral leukemia cell death. Anticipate, monitor for signs and symptoms and treat promptly.
  • Clofarabine may cause a cytokine release syndrome (e.g., tachypnea, tachycardia, hypotension, pulmonary edema) that may progress to the systemic inflammatory response syndrome (SIRS) with capillary leak syndrome and organ impairment which may be fatal. Monitor for and discontinue Clofarabine immediately if suspected.
  • Patients who have previously received a hematopoietic stem cell transplant (HSCT) are at higher risk for veno-occlusive disease (VOD) of the liver following treatment with clofarabine. Monitor for and discontinue Clofarabine if suspected.
  • Severe and fatal hepatotoxicity, including hepatitis and hepatic failure, has occurred with the use of Clofarabine. Severe and fatal hepatotoxicity. Monitor liver function, for signs and symptoms of hepatitis and hepatic failure. Discontinue Clofarabine immediately for Grade 3 or greater liver enzyme and/or bilirubin elevations.
  • Clofarabine may cause acute renal failure. Increased creatinine and acute renal failure; monitor renal function and interrupt or discontinue Clofarabine.
  • Fatal and serious cases of enterocolitis, including neutropenic colitis, cecitis, and C. difficile colitis, have occurred during treatment with clofarabine. Serious and fatal enterocolitis, occurring more frequently within 30 days of treatment and with combination chemotherapy. Monitor patients for signs and symptoms of enterocolitis and treat promptly.
  • Serious and fatal cases of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported. Discontinue for exfoliative or bullous rash, or if SJS or TEN is suspected.
  • Based on findings from animal reproductive studies and the drug's mechanism of action, Clofarabine can cause fetal harm when administered to a pregnant woman. Advise males with female partners of reproductive potential to use effective contraception during treatment with Clofarabine and for at least 3 months after the last dose.


What to do in case of emergency/overdose?[edit | edit source]

Symptoms of overdosage may include:

Management of overdosage:

  • In the event of an overdose, appropriate supportive treatment should be initiated.


Can this medicine be used in pregnancy?[edit | edit source]

  • There are no available data on Clofarabine use in pregnant women to evaluate for a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes.
  • Clofarabine should be used during pregnancy only if the potential benefits to the mother outweigh the potential risks, including those to the fetus.


Can this medicine be used in children?[edit | edit source]


What are the active and inactive ingredients in this medicine?[edit | edit source]

Active ingredient:

  • CLOFARABINE

Inactive ingredients:

  • SODIUM CHLORIDE
  • WATER


Who manufactures and distributes this medicine?[edit | edit source]

Manufactured for:

  • Fresenius
  • Lake Zurich, IL
  • www.fresenius-kabi.com/us
  • Made in India


What should I know about storage and disposal of this medication?[edit | edit source]

  • Vials containing undiluted Clofarabine Injection should be stored at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
  • Do not freeze.
  • Retain in carton until contents are used.
  • Clofarabine is a cytotoxic drug.
  • Follow applicable special handling and disposal procedures.


{{coststubd}Alphabetic list of antineoplastic agents - 0-9 - A1 - A2 - A3 - A4 - A5 -A6 - B - C - D - E - F - G - H - I - JK - L - M - NO - PQ - R - S - T - UVW - XYZ


Clofarabine Resources
Wikipedia

WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Contributors: Deepika vegiraju